Stocklytics Platform
Asset logo for symbol SGRY
Surgery Partners
SGRY55
$22.82arrow_drop_up0.79%$0.17
Asset logo for symbol SGRY
SGRY55

$22.82

arrow_drop_up0.79%
Key Stats
Open$22.26
Prev. Close$22.60
EPS-0.47
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range22.39
22.84
52 Week Range18.00
36.91
Ratios
EPS-0.47
Fundamentals
Payout Ratio-
Industry average yield2.89%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

SGRY-
US Healthcare Sector-
US Market-
check_circle

SGRY / Market

SGRY exceeded the US Market which returned 0.03% over the last twenty four hours.
warning

SGRY / Healthcare Sector

SGRY lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.

Surgery Partners (SGRY) Statistics

Surgery Partners Inc (SGRY) is a healthcare services company that operates surgical facilities and ancillary services. The company's valuation metrics indicate its market value and financial health. SGRY has a market capitalization of $973.52 million and a price-to-earnings ratio of -0.70, suggesting that it has negative earnings. Its price-to-sales ratio stands at 0.29, indicating that investors are paying $0.29 for every dollar of revenue generated by the company. Furthermore, the price-to-book ratio is 2.42, reflecting a higher valuation compared to its book value per share. These metrics provide an overview of SGRY's market worth and relative valuation.
In terms of fundamentals, SGRY has a strong focus on revenue growth. The company's revenue per share is $477.37, indicating its ability to generate significant sales. Moreover, SGRY has an Enterprise to EBITDA ratio of 13.10, showing that it is efficiently using its assets to generate earnings. Additionally, the company has a profit margin of -5.81%, suggesting that it operates with a slight loss. SGRY also carries a considerable amount of debt, with a total debt of $1.27 billion, which could impact its financial stability. Lastly, SGRY's gross profit is $358.23 million, demonstrating its ability to generate profits after deducting production costs.
add Surgery Partners  to watchlist

Keep an eye on Surgery Partners

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Surgery Partners (SGRY) stock's performance compared to its sector and the market over the past year?

Over the past year, Surgery Partners (SGRY) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Surgery Partners has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Surgery Partners 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Surgery Partners (SGRY) stock?

The PE ratio for Surgery Partners (SGRY) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Surgery Partners (SGRY) stock?

The Earnings Per Share (EPS) for Surgery Partners (SGRY), calculated on a diluted basis, is -$0.47. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Surgery Partners (SGRY) stock?

The operating margin for Surgery Partners (SGRY) is 13.02%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Surgery Partners (SGRY) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Surgery Partners (SGRY) is $614.1M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Surgery Partners (SGRY) have?

Surgery Partners (SGRY) has a total debt of $3.53B. The net debt, which accounts for cash and cash equivalents against the total debt, is $3.3B.

Take Your Investments to a Whole New Level